Evolutionary Genomics, Inc. Stock
Stocks
FNAM
US30051F1012
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:27:27 2023-07-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.5100 USD | -27.14% |
|
+254,900.00% | +254,900.00% |
| 23-03-09 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 23-03-08 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 2.99M 2.68M 2.5M 2.27M 4.28M 286M 4.3M 30.03M 11.76M 148M 11.25M 11M 475M | P/E 2021 |
-1.34x | P/E 2022 | -2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16M 5.52M 5.14M 4.66M 8.8M 589M 8.85M 61.79M 24.19M 304M 23.15M 22.63M 978M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
67.35% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -27.14% | ||
| 1 week | +254,900.00% | ||
| Current month | +254,900.00% | ||
| 1 month | +254,900.00% | ||
| 3 months | +254,900.00% | ||
| 6 months | +254,900.00% | ||
| Current year | +254,900.00% |
| 1 year | 0 | 0.51 | |
| 3 years | 0 | 0.51 | |
| 5 years | 0 | 0.9 | |
| 10 years | 0 | 5.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Walter Messier
CTO | Chief Tech/Sci/R&D Officer | 71 | 1999-12-31 |
Steve Warnecke
CEO | Chief Executive Officer | 70 | 2014-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Warnecke
CHM | Chairman | 70 | 2014-09-30 |
| Director/Board Member | 76 | 1999-12-31 | |
Mark Boggess
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/23/22 | Exercice | Chief Executive Officer | 185,715 | 2.8074% | ||
| 5/23/22 | Exercice | Founder | 278,571 | 4.2111% | ||
| 5/23/22 | Exercice | Founder | 55,714 | 0.8422% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -27.14% | +254,900.00% | +254,900.00% | +13.33% | 1.33K | ||
| +0.03% | -5.67% | +50.74% | +76.76% | 70.65B | ||
| -0.38% | -12.51% | +4.70% | +54.09% | 51.22B | ||
| -0.89% | -1.28% | +7.44% | +36.04% | 48.04B | ||
| +0.90% | -1.46% | +32.32% | +32.69% | 43.16B | ||
| +2.21% | -6.61% | +302.05% | +701.45% | 41.57B | ||
| -1.15% | -3.11% | +9.47% | +98.83% | 39.84B | ||
| +0.45% | -1.20% | +9.11% | +43.54% | 30.87B | ||
| -2.66% | -11.49% | +42.12% | +4.38% | 27.53B | ||
| -1.16% | -1.84% | -6.09% | -11.99% | 24.08B | ||
| Average | -2.98% | -3.08% | +25,535.19% | +104.91% | 37.7B | |
| Weighted average by Cap. | -0.17% | -3.47% | +52.54% | +120.99% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.79M -2.5M -2.33M -2.11M -3.99M -267M -4.01M -28.02M -10.97M -138M -10.5M -10.26M -444M | -1.93M -1.73M -1.61M -1.46M -2.76M -185M -2.78M -19.41M -7.6M -95.45M -7.27M -7.11M -307M |
| Net Debt | 3.53M 3.16M 2.95M 2.67M 5.04M 337M 5.07M 35.4M 13.86M 174M 13.26M 12.97M 560M | 3.17M 2.83M 2.64M 2.4M 4.52M 303M 4.55M 31.76M 12.43M 156M 11.9M 11.63M 503M |
Employees
3
- Stock Market
- Stocks
- FNAM Stock
Select your edition
All financial news and data tailored to specific country editions
















